메뉴 건너뛰기




Volumn 13, Issue 4, 2013, Pages 417-423

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma

Author keywords

BEAM; Carmustine; CBV; Chemosensitivity; Hematopoietic transplantation; High dose chemotherapy

Indexed keywords

ANTIINFECTIVE AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

EID: 84880710848     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2013.03.009     Document Type: Article
Times cited : (29)

References (40)
  • 1
    • 68049131240 scopus 로고    scopus 로고
    • Salvage therapy for Hodgkin's lymphoma
    • F. Quddus, and J.O. Armitage Salvage therapy for Hodgkin's lymphoma Cancer J 15 2009 161 163
    • (2009) Cancer J , vol.15 , pp. 161-163
    • Quddus, F.1    Armitage, J.O.2
  • 2
    • 0027404777 scopus 로고
    • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
    • DOI 10.1016/0140-6736(93)92411-L
    • D.C. Linch, D. Winfield, and A.H. Goldstone Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial Lancet 341 1993 1051 1054 (Pubitemid 23114397)
    • (1993) Lancet , vol.341 , Issue.8852 , pp. 1051-1054
    • Linch, D.C.1    Winfield, D.2    Goldstone, A.H.3    Moir, D.4    Hancock, B.5    McMillan, A.6    Chopra, R.7    Milligan, D.8    Vaughan Hudson, G.9
  • 5
    • 0027324921 scopus 로고
    • The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease
    • A.H. Goldstone, and A.K. McMillan The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease Ann Oncol 4 suppl 1 1993 21 27 (Pubitemid 23190844)
    • (1993) Annals of Oncology , vol.4 , Issue.SUPPL. 1 , pp. 21-27
    • Goldstone, A.H.1    McMillan, A.K.2
  • 6
    • 3342932858 scopus 로고
    • Autologous bone marrow transplantation for lymphoma: A 15-year European bone marrow transplant registry (EBMT) experience of 3325 patients
    • A.K. Fielding, T. Philip, and A. Carella Autologous bone marrow transplantation for lymphoma: a 15-year European bone marrow transplant registry (EBMT) experience of 3325 patients ASH Annual Meeting Abstracts 84 1994 169
    • (1994) ASH Annual Meeting Abstracts , vol.84 , pp. 169
    • Fielding, A.K.1    Philip, T.2    Carella, A.3
  • 11
    • 0030938978 scopus 로고    scopus 로고
    • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
    • S.J. Horning, N.J. Chao, and R.S. Negrin High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices Blood 89 1997 801 813 (Pubitemid 27121273)
    • (1997) Blood , vol.89 , Issue.3 , pp. 801-813
    • Horning, S.J.1    Chao, N.J.2    Negrin, R.S.3    Hoppe, R.T.4    Long, G.D.5    Hu, W.W.6    Wong, R.M.7    Brown, B.W.8    Blume, K.G.9
  • 13
    • 0029072508 scopus 로고
    • High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
    • D.E. Reece, M.J. Barnett, and J.D. Shepherd High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy Blood 86 1995 451 456
    • (1995) Blood , vol.86 , pp. 451-456
    • Reece, D.E.1    Barnett, M.J.2    Shepherd, J.D.3
  • 16
    • 70349207133 scopus 로고    scopus 로고
    • Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma
    • N.S. Majhail, R. Bajorunaite, and H.M. Lazarus Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma Br J Haematol 147 2009 129 139
    • (2009) Br J Haematol , vol.147 , pp. 129-139
    • Majhail, N.S.1    Bajorunaite, R.2    Lazarus, H.M.3
  • 17
    • 0025912707 scopus 로고
    • High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease
    • A. Kessinger, P.J. Bierman, and J.M. Vose High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease Blood 77 1991 2322 2325
    • (1991) Blood , vol.77 , pp. 2322-2325
    • Kessinger, A.1    Bierman, P.J.2    Vose, J.M.3
  • 18
    • 0025991771 scopus 로고
    • Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease
    • D.E. Reece, M.J. Barnett, and J.M. Connors Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 9 1991 1871 1879
    • (1991) J Clin Oncol , vol.9 , pp. 1871-1879
    • Reece, D.E.1    Barnett, M.J.2    Connors, J.M.3
  • 19
    • 0029918551 scopus 로고    scopus 로고
    • High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy
    • P.J. Bierman, J.R. Anderson, and M.B. Freeman High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy Ann Oncol 7 1996 151 156 (Pubitemid 26094879)
    • (1996) Annals of Oncology , vol.7 , Issue.2 , pp. 151-156
    • Bierman, P.J.1    Anderson, J.R.2    Freeman, M.B.3    Vose, J.M.4    Kessinger, A.5    Bishop, M.R.6    Armitage, J.O.7
  • 22
    • 0028941380 scopus 로고
    • BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma
    • W. Mills, R. Chopra, and A. McMillan BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma J Clin Oncol 13 1995 588 595
    • (1995) J Clin Oncol , vol.13 , pp. 588-595
    • Mills, W.1    Chopra, R.2    McMillan, A.3
  • 23
    • 0033735870 scopus 로고    scopus 로고
    • High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease
    • A. Argiris, S. Seropian, and D.L. Cooper High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease Ann Oncol 11 2000 665 672
    • (2000) Ann Oncol , vol.11 , pp. 665-672
    • Argiris, A.1    Seropian, S.2    Cooper, D.L.3
  • 29
    • 0030463127 scopus 로고    scopus 로고
    • Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors
    • DOI 10.1016/S0966-3274(96)80054-2
    • H.T. Hassan, M. Stockschlader, and B. Schleimer Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors Transpl Immunol 4 1996 319 323 (Pubitemid 27019627)
    • (1996) Transplant Immunology , vol.4 , Issue.4 , pp. 319-323
    • Hassan, H.T.1    Stockschlader, M.2    Schleimer, B.3    Kruger, W.4    Zander, A.R.5
  • 33
    • 0027534424 scopus 로고
    • The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients
    • R. Chopra, A.K. McMillan, and D.C. Linch The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 81 1993 1137 1145 (Pubitemid 23067347)
    • (1993) Blood , vol.81 , Issue.5 , pp. 1137-1145
    • Chopra, R.1    McMillan, A.K.2    Linch, D.C.3    Yuklea, S.4    Taghipour, G.5    Pearce, R.6    Patterson, K.G.7    Goldstone, A.H.8
  • 35
    • 0031967030 scopus 로고    scopus 로고
    • Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)
    • DOI 10.1023/A:1008283909959
    • A. Josting, I. Katay, and U. Rueffer Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM) Ann Oncol 9 1998 289 295 (Pubitemid 28186799)
    • (1998) Annals of Oncology , vol.9 , Issue.3 , pp. 289-295
    • Josting, A.1    Katay, I.2    Rueffer, U.3    Winter, S.4    Tesch, H.5    Engert, A.6    Diehl, V.7    Wickramanayake, P.D.8
  • 36
    • 0034663188 scopus 로고    scopus 로고
    • Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group
    • A. Josting, U. Rueffer, and J. Franklin Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group Blood 96 2000 1280 1286 (Pubitemid 30658456)
    • (2000) Blood , vol.96 , Issue.4 , pp. 1280-1286
    • Josting, A.1    Rueffer, U.2    Franklin, J.3    Sieber, M.4    Diehl, V.5    Engert, A.6
  • 37
    • 0027146193 scopus 로고
    • One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
    • A.P. Rapoport, J.M. Rowe, and P.A. Kouides One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome J Clin Oncol 11 1993 2351 2361
    • (1993) J Clin Oncol , vol.11 , pp. 2351-2361
    • Rapoport, A.P.1    Rowe, J.M.2    Kouides, P.A.3
  • 39
    • 0026439199 scopus 로고
    • Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
    • G.P. Canellos, J.R. Anderson, and K.J. Propert Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD N Engl J Med 327 1992 1478 1484
    • (1992) N Engl J Med , vol.327 , pp. 1478-1484
    • Canellos, G.P.1    Anderson, J.R.2    Propert, K.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.